CarboCode Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$16M
- Investors
-
3
CarboCode General Information
Description
Operator of a biotechnology company intended to create missing components of human milk and prevent and fight against age-related cognitive decline and neurodegenerative diseases. The company is focused on the technology development, production, and commercialization of glycosphingolipids and their precursors, enabling physicians to provide nutritional alternatives for enhancing the cognitive capabilities of all age groups.
Contact Information
Website
www.carbocode.comCorporate Office
- Technology Transfer Center
- Parque Tecnológico de Cantanhede, Núcleo 04, Lote 2
- Cantanhede, Coimbra 3060-197
- Portugal
Corporate Office
- Technology Transfer Center
- Parque Tecnológico de Cantanhede, Núcleo 04, Lote 2
- Cantanhede, Coimbra 3060-197
- Portugal
CarboCode Timeline
CarboCode Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series C) | 28-Nov-2024 | $16M | Completed | Pre-Clinical Trials | ||
| 4. Later Stage VC (Series B2) | 01-Feb-2023 | Completed | Product Development | |||
| 3. Early Stage VC | 01-Oct-2020 | Completed | Product Development | |||
| 2. Early Stage VC | 01-Mar-2019 | $20.4M | $22.7M | Completed | Startup | |
| 1. Seed Round | 01-Mar-2017 | $2.29M | $2.29M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
CarboCode Patents
CarboCode Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026215810-A1 | Composition for restoring and/or maintaining gut barrier function | Pending | 08-Apr-2025 | ||
| WO-2026033360-A1 | Method for the production of sphingolipids | Pending | 05-Aug-2024 | ||
| WO-2025169087-A1 | Composition comprising glycosphingolipids | Pending | 05-Feb-2024 | ||
| WO-2025133966-A1 | Production of glucosylceramide | Inactive | 22-Dec-2023 | ||
| EP-4783879-A1 | Composition comprising glycosphingolipids for young child applications | Pending | 28-Sep-2023 | A23L33/40 |
CarboCode Signals
CarboCode Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Iberis Capital | Venture Capital | Minority | ||
| Bits x Bites | Venture Capital | Minority | ||
| Green Innovations | Venture Capital | Minority |
CarboCode FAQs
-
When was CarboCode founded?
CarboCode was founded in 2017.
-
Where is CarboCode headquartered?
CarboCode is headquartered in Cantanhede, Portugal.
-
What is the size of CarboCode?
CarboCode has 62 total employees.
-
What industry is CarboCode in?
CarboCode’s primary industry is Biotechnology.
-
Is CarboCode a private or public company?
CarboCode is a Private company.
-
What is the current valuation of CarboCode?
The current valuation of CarboCode is .
-
What is CarboCode’s current revenue?
The current revenue for CarboCode is .
-
How much funding has CarboCode raised over time?
CarboCode has raised $82.2M.
-
Who are CarboCode’s investors?
Iberis Capital, Bits x Bites, and Green Innovations have invested in CarboCode.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process